MedPath

Chlamydia Screening Implementation Project

Conditions
Chlamydia trachomatis
std
venereal disease
10008555
Registration Number
NL-OMON32112
Lead Sponsor
Zorgonderzoek Nederland (ZON)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
315000
Inclusion Criteria

16-29 age bracket
sexual active
registred in standard municipal registers of Amsterdam/Rotterdam/South Limburg

Exclusion Criteria

Younger than 16 years
Older than 29 years
not sexual active

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>· Response rate of 30% (individuals who actually send in their samples to the<br /><br>laboratory)<br /><br>· Ct-positivity rate between 3-5%</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Impact of Chlamydia screening on ct-prevalence (which can be achieved by<br /><br>chlamydia trend analysis) and the impact on PID-rates.<br /><br>The results of this implementation will be leading for the decision about the<br /><br>national roll-out of screening in the Netherlands.</p><br>
© Copyright 2025. All Rights Reserved by MedPath